Skip to main content
. 2015 Feb 7;16(1):20. doi: 10.1186/s12931-015-0175-9

Figure 3.

Figure 3

FEV 1 AUC (0–3h) response after 4 weeks of treatment (full analysis set). Adjusted for ‘treatment’, ‘period’, ‘patient’ and ‘baseline’. *p < 0.05; ***p < 0.001 versus placebo Respimat®. AUC(0–3h), area under the curve within 3 hours post-dosing; FEV1, forced expiratory volume in 1 second.